09:13 AM EDT, 08/16/2024 (MT Newswires) -- Health care stocks were leaning lower premarket Friday, with the Health Care Select Sector SPDR Fund ( XLV ) and iShares Biotechnology ETF ( IBB ) marginally declining recently.

BioNTech (BNTX) shares were down more than 3% after the biotech firm and Pfizer ( PFE ) reported that their phase 3 study assessing a combined mRNA vaccine candidate targeting influenza and COVID-19 missed one of two primary immunogenicity targets.

Alvotech ( ALVO ) shares were up more than 5% after it reported an H1 revenue of about $235.6 million, compared with $20.3 million a year earlier.

Incyte ( INCY ) shares were more than 1% higher after saying its cancer drug Monjuvi met the primary goal of a phase 3 study by showing progression-free survival in patients with relapsed or refractory follicular lymphoma.